AT1 FY21 - General Discussion + FA, page-433

Welcome to AT1.

No one has access to production costs information - that's company confidential info - we can draw inferences/make assumption/guesstimates based on available financial data. You should have already seen plenty of posts about the profit/rev/margin info, right?

If you have read every HC post + reviewed all the available media/interviews etc...you have access to everything already to draw your conclusions on the risks, potential etc + what other posters have already discussed in terms of earnings, rev, growth possibilities etc.

The SP is stagnant (though weirdly stable in low 30cs despite market volatility for similar diagnostics stocks) b/c everyone awaits several pending test approvals + subsequent potential revenue trends + further news of HIV test expansion underway...and possibly the next qtrly/half-yearly to see where the company is heading.

Its also the same reason why you are not seeing any recent new posts/discussions (though the media thread still gets a few per week)...there is nothing to say/discuss at this stage...everything past has been poked/proddded/turned over fairly thoroughly, as you will have seen in these threads.

In regards to no competition, I presume you are referring to AT1's integrated device design..and not the complete POCT options, right? B/c for the various Covid19 + HIV complete test kits, there is plenty of in-market competition but none with AT1's patented POCT design (except the Ag tests which are AccBio's original kit).